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To study Mason-Pfizer monkey virus (MPMV) replication over a single round, virus particles were generated that
contain a replication-defective vector encoding a dominant selectable marker, the hygromycin B phosphotransferase
(hygr) gene. Genetic complementation with a homologous MPMV envelope glycoprotein (Env-gp) or pseudotyping by
several heterologous Env-gps from a variety of viruses resulted in infectious MPMV particles containing the replication-
defective RNA. Recently, it has been shown that human immunodeficiency virus type 1 (HIV-1) and simian immunodefi-
ciency virus (SIV) Rev and Rev-responsive element (RRE) functions can be substituted in vitro by a cis-acting sequence,
the constitutive transport element (CTE), from simian type D retroviruses like MPMV and simian retrovirus type 1 (SRV-
1). To determine whether CTE of MPMV is necessary for MPMV nucleic acid propagation, an MPMV vector that lacked
the terminally located CTE was generated. Propagation of this vector was completely abrogated in the absence of CTE,
showing the importance of CTE in MPMV replication. Insertion of CTE back into the MPMV genome in the sense
orientation rescued replication to wild-type levels. Slot-blot analysis of nuclear versus cytoplasmic RNA fractions
revealed that most of the messages were sequestered in the nucleus of cells transfected with the CTE(0) vectors and
very little was transported to the cytoplasm. To test whether HIV-1 or SIV RREs could complement CTE function, the
HIV-1 or SIV RREs were inserted in the CTE(0) vectors. trans complementation of CTE(0)RRE(/) vectors with Env- and
Rev- expression plasmids rescued propagation of the CTE(0) vectors. Computer analysis predicted an RNA secondary
structure in MPMV CTE analogous to the HIV-1 and SIV RREs that could form three stable stem loops, the first of
which contains a site similar to the Rev-binding domain in the HIV-1 RRE. The presence of a higher-order CTE structure
was analyzed by mutational analysis. We conclude that CTE is important in the replication of MPMV and affects the
nucleocytoplasmic transport and/or stability of viral messages similar to the Rev/RRE regulatory system of HIV-1 and
SIV. q 1996 Academic Press, Inc.
INTRODUCTION gp) (Sonigo et al., 1986). Unlike type C retroviruses that
carry out assembly and budding simultaneously at the
Mason-Pfizer monkey virus (MPMV) is a prototypic cell membrane, MPMV preassembles its immature cap-
type D primate retrovirus that was originally isolated from sid proteins in the cytoplasm before budding at the cell
a spontaneous breast carcinoma of a female rhesus membrane, releasing infectious virions (Fine and Scho-
monkey (Chopra and Mason, 1970; Jensen et al., 1970). chetman, 1978). Not much is known about MPMV replica-
Since its initial discovery, rather than being found onco- tion and cellular targets of MPMV infection.
genic, it has been implicated with simian acquired immu- Recently, a small 219-bp cis-acting element, the consti-
nodeficiency syndrome (SAIDS) in newborn rhesus ma- tutive transport element (CTE), present in the 3* region of
caques (Daniel et al., 1984; Marx et al., 1984; Stromberg MPMV and SRV-1 was implicated in interacting with cellu-
et al., 1984). MPMV closely resembles other type D re- lar pathways normally used for the transport of cellular
troviruses that also cause SAIDS, simian retrovirus type mRNAs from the nucleus to the cytoplasm (Bray et al.,
1 and type 2 (SRV-1 and SRV-2) (Power et al., 1986; 1994; Zolotukhin et al., 1994). In complex retroviruses like
Thayer et al., 1987). It contains three genes in the order human immunodeficiency virus type 1 (HIV-1) and simian
5*-gag-pol-env-3* where gag encodes the structural immunodeficiency virus (SIV), transport of spliced and un-
genes, pol the viral aspartyl protease and the reverse spliced messages is regulated by the virally encoded Rev
transcriptase, and env the envelope glycoprotein (Env- protein, which interacts with a short cis-acting sequence,
the Rev-responsive element (RRE), found in their env
genes (reviewed by Cullen, 1992). Similarly, the MPMV1 To whom reprint requests should be addressed at Department of
and SRV-1 CTEs, once inserted before the polyadenylationVeterinary Sciences, The University of Texas M. D. Anderson Cancer
sequences of expression vectors expressing either gag/Center, Route 2, Box 151-B1, Bastrop, TX 78602. Fax: 512-332-5208. E-
mail: tarfm@aol.com. pol or env genes of HIV-1 and SIV, or in the nef gene of
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Rev(0) and RRE(0) molecular clones of HIV-1 or SIV, vector was completely abrogated in the absence of CTE,
while insertion of the CTE back into the genome in thecause the viral mRNA expression to become independent
of the Rev/RRE regulatory system (Bray et al., 1994; Zolo- sense orientation rescued MPMV replication to almost
wild-type levels. Further analysis of the fractionatedtukhin et al., 1994; Rizvi et al., 1996). These Rev/RRE-de-
pendent HIV-1 mRNAs contain several cis-acting repres- mRNAs revealed that most of the messages were se-
questered in the nucleus of cells transfected with thesor or negative inhibitory sequences (CRS or INS) that
trap these unspliced or partially spliced messages in the CTE(0) vectors and very little was transported to the
cytoplasm. When HIV-1 or SIV RREs were inserted innucleus, destabilize them, and/or prevent their association
with the polysomes (Rosen et al., 1988; Cochrane et al., the CTE(0) vector and trans complemented with Rev-
expressing plasmids, vector propagation was rescued,1991; Maldarelli et al., 1991; Schwartz et al., 1992a; Nasi-
oulas et al., 1994; Brighty and Rosenberg, 1994). In the albeit at a lower efficiency compared with MPMV vectors
containing CTE. Secondary RNA structure analysis ofabsence of Rev, these messages remain sequestered in
the nucleus until they are spliced, exported out, or de- CTE indicated that it had the potential to form three stable
stem loops, one of which contained a site reminiscentgraded (Emerman et al., 1989; Felber et al., 1989; Malim
et al., 1989a). Rev binds to RREs found in these messages to the Rev-binding sequences in the HIV-1 RRE. Deletion/
insertional mutation analysis suggested the presence ofand allows their expression by transporting them to the
cytoplasm (Felber et al., 1989; Hammarskjold et al., 1989; an RNA secondary structure of CTE. Together, these re-
sults suggest that CTE is critical for the regulation offor more references, see review by Cullen, 1992). Rev
may accomplish this by interacting with cellular cofactors MPMV gene expression and functions in the viral life
cycle by interacting with constitutively present cellularinvolved in the nucleocytoplasmic transport of cellular
messages (Bogerd et al., 1995; Stutz et al., 1995; Fischer factors analogous to the Rev/RRE regulatory system of
HIV/SIV.et al., 1995; Fritz et al., 1995). Interestingly, in hepatitis B
virus (HBV), a DNA virus that replicates by using reverse
transcription of an RNA intermediate, a CTE/RRE-like ele- MATERIALS AND METHODS
ment has been discovered (Huang and Liang, 1993; Hu-
Numbering systemang and Yen, 1994). Similar to the HIV-1 and SIV RREs,
it regulates gene expression by inhibiting splicing and Nucleotide designations for MPMV, SIVmac239, and
facilitating the nucleocytoplasmic transport and utilization HIV-1-NL4-3 are based on GenBank Accession Nos.
of HBV messages. M12349 (Sonigo et al., 1986), M33262 (Kestler et al.,
We were interested in studying the role of CTE in the 1990), and M19921 (Adachi et al., 1986), respectively.
replication of MPMV and in examining whether its func-
tion was similar to the function of Rev/RRE in the life Construction of MPMV vectors
cycle of the virus. Since the Rev/RRE regulates the ex-
pression of viral messages by affecting splicing as well All plasmids were made by standard molecular cloning
techniques. A 234-bp XhoI–BamHI fragment from p1234as transport and stability of messages, we wanted to
explore the possibility that MPMV, being a simple retrovi- (kindly provided by Dr. Marie-Louise Hammarskjold) con-
taining the MPMV CTE was subcloned into the XhoI –rus, controls splicing in a manner similar to those found
in other simple retroviruses. Splicing in simple retrovi- BamHI sites of pIC19H (Marsh et al., 1984) in order to
acquire multiple cloning sites at both ends, resulting inruses is controlled by regulatory functions that allow the
formation of incompletely spliced products (reviewed by pTR225. pKAL001 contains the entire MPMV genome
(Fig. 1) and was constructed by removing an XbaI–EcoRICoffin, 1985, and Stoltzfus, 1988). Regulation of splicing
may occur at the level of inefficient splice site usage or fragment from pSHRM15 (kindly provided by Dr. Eric
Hunter) and cloning into the XbaI and EcoRI sites ofmRNA instability (Arrigo and Beemon, 1988; Katz and
Skalka, 1990). In addition, it is possible that cis-acting pIC19H. Clone pKAL036, which contains a deletion in
the env gene with a simultaneous insertion of the ‘‘SV40-sequences present in other parts of the genome interfere
with the splicing machinery directly by acting as negative Hygr’’ cassette (Fig. 1), was constructed through several
steps: first, a HindIII site [nucleotide (nt) 7886] in the envinhibitory elements (Stoltzfus and Fogarty, 1989) or facili-
tate the transport of unspliced messages by acting as gene of pKAL001 was blunted with the Klenow enzyme
(New England Biolabs, Cambridge, MA) and ligated toCTEs (Bray et al., 1994; Zolotukhin et al., 1994).
To study MPMV replication, a trans complementation an NheI linker. Next, an NheI–NheI fragment containing
the ‘‘SV40-Hygr’’ cassette was inserted in the NheI siteassay was developed that allows study of viral replication
over a single round. This assay allowed us to study the in the sense orientation with the simultaneous deletion
of 705 bp in env.role of CTE in MPMV replication in a clear and quantita-
tive manner. Toward this end, a modified version of an pKAL013 was an intermediate clone constructed by
ligating the 1432-bp NheI–SmaI fragment from pKAL001Env(0) MPMV vector was created that lacked the termi-
nally located CTE and contained an insertion of the into the NheI–EcoRV sites of pTR276. pKAL013 contains
MPMV sequences from the NheI site (nt 7181) in the env‘‘SV40-Hygr’’ cassette in the env gene. Propagation of this
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FIG. 1. Schematic representation of the MPMV genome (pKAL001) with open reading frames (ORFs) and MPMV vectors with the insertion of the
‘‘SV40 Hygr’’ cassette in the env region. Details of the origin and construction of these plasmids are presented under Materials and Methods. The
dotted lines represent the extent of deletions introduced in the various vectors to abolish Env ORF and maintain or remove the MPMV CTE. RRE,
Rev-responsive element; SV, simian virus 40 early promoter; hygr, hygromycin B phosphotransferase gene.
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FIG. 2. Deletion introduced in the MPMV genome using splice overlap extension (SOE) PCR removing parts of env and CTE. The first schematic
represents the 3* end of MPMV genome followed by the PCR amplification strategy used for introducing the deletion shown in the gray shaded
area. Two rounds of PCR were performed to construct the deletion with the first round of PCR representing two separate reactions (see Materials
and Methods for details). The MPMV CTE is shown as a black box. Annealing sites of PCR amplification primers used are shown with respect to
the 3* LTR. Portions of hybrid primers that do not anneal are shown with offset portions. Cell DNA is shown in thick lines.
gene to the SmaI site in the cellular DNA at the 3* end. encompassing the PPT, shown in lowercase, followed by
env nt 7578–7564, shown in uppercase). These primersA deletion in the env gene and CTE was made by using
the splice overlap extension (SOE) PCR strategy (Gibbs created a deletion in MPMV env and most of CTE. The
PCR amplification generated a fragment (product 1a)et al., 1994). This strategy required conducting two sepa-
rate rounds of PCR (Fig. 2). The first round of PCR con- containing nt 7121–7578 of the MPMV env gene with a
6-bp region (PPT ‘‘tail’’) at the 3* end complementary tosisted of two separate reactions using pKAL001 as the
template. The first reaction used sense (S) primer 6 bp of the CTE region starting just upstream of the PPT.
The second reaction used S hybrid primer OTR183f (5*OTR143 (5* GATTCCAATTGCCTTTACGC 3*; MPMV env
nt 7121–7140) and antisense (AS) hybrid primer OTR183r AGATCTattaaaaagggtgac 3*; MPMV nt 7573–7578 in
env, shown in uppercase, followed by nt 8191–8205,(5* tttaatAGATCTTGTATAGTG 3*; MPMV nt 8196–8191,
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shown in lowercase), creating a 424-bp deletion in env
and a 180-bp deletion in the CTE, and AS primer OTR146
(5* CCCGGGAATTCGCGGTACCC 3*) encompassing se-
quences in cell DNA downstream of the 3* LTR of the
pSHRM15 clone. This reaction produced a fragment
(product 1b) containing the PPT immediately upstream
from the 3* LTR and some cellular DNA sequences imme-
diately downstream from the 3* LTR; the 5* end of this
fragment contains a 6-bp region (env ‘‘tail’’) corresponding FIG. 3. Schematic representation of MPMV and A-MLV Env-gp ex-
pression constructs in the presence or the absence of MPMV CTE.to nt 7573–7578 in the MPMV env gene and containing
pTR287 and pTR283 express the MPMV Env-gp from the SV40 earlya BglII site. The two PCR reactions allowed addition of
promoter and uses the SV40 poly(A) in the presence or the absencecomplementary sequences to the appropriate ends of
of the MPMV CTE. pSV-A-MLV-env expresses the A-MLV Env-gp from
MPMV env and PPT to enable joining of these sequences the MLV LTR and contains the SV40 enhancer promoter and SV40
in a subsequent round of PCR (Fig. 2). All PCR reactions poly(A). Details of the origin and construction of these plasmids are
presented under Materials and Methods. MPMV CTE is shown as awere conducted in the Perkin–Elmer Cetus 9600 block
stippled box. SV40, simian virus 40 early promoter; A-MLV, amphotropicthermocycler (Perkin–Elmer, Foster City, CA). The PCR
murine leukemia virus; poly(A), polyadenylation sequences.reactions were performed in 50-ml volumes using the
GeneAmp PCR reagent kit with native Taq polymerase
(Perkin–Elmer). Conditions for PCR were as follows: an opposite orientation was named pKAL044. Since
initial denaturation step at 947 for 5 min, followed by a pKAL048 retained 46 bp of the CTE (overlapping with
cycling program of 947 for 45 sec, 557 for 45 sec, and PPT and the U3 region of the 3* LTR), pKAL039 and
727 for 2 min for 30 cycles, followed by a final extension pKAL044 contain a 46-bp duplication of the CTE (Fig. 1).
step at 727 for 7 min, and finally cooling to 47. Products To replace the MPMV CTE with HIV-1 RRE, a fragment
1a and 1b were purified by the QIAquick PCR purification from pNL4-3 containing HIV-1 RRE (nt 7610–8130) was
kit (Qiagen, Chatsworth, CA). A second round of PCR inserted at the BglII site of pKAL048. The clone con-
was performed using products 1a and 1b as templates taining the HIV-1 RRE in the sense orientation was
and primers OTR143 and OTR146 under the same ampli- named pKAL051, while pKAL052 contained the HIV-1
fication conditions as described above but only for 10 RRE in the antisense orientation (Fig. 1).
cycles (Fig. 2). The final PCR product was isolated by To replace the MPMV CTE with SIVmac239 RRE, a
agarose gel electrophoresis and purified by the Prep-A- fragment from p239SpE3* (Kestler et al., 1990) containing
Gene kit (Bio-Rad, Hercules, CA). The gel-purified PCR SIVmac239 RRE (nt 8329–8725) was inserted at the BglII
product was digested with NheI and SphI and ligated site of pKAL048. The clone containing the SIVmac239
into the NheI– SphI sites of pKAL013, creating pKAL014, RRE in the sense orientation was named pKAL053, while
which contains a 613-bp deletion of nt 7578–8191. Se- pKAL054 contained the SIVmac239 RRE in the antisense
quences including the PPT and 3* LTR, along with the orientation.
flanking regions, were verified by the Promega ‘‘fmol DNA To disrupt the predicted RNA secondary structure of
Cycle Sequencing System’’ using the end-labeled primer MPMV CTE, PCR was used to make deletions and inser-
method (Promega, Madison, WI). pKAL014 was digested tional mutations in CTE. This was achieved by creating
with NheI– EcoRI and the PCR-amplified product was a BglII site in stem loop III at position A (nt 8190/8191) in
cloned into the NheI– EcoRI sites of pKAL001. Simultane- CTE which was cloned into the CTE(0) vector, pKAL048,
ously, an NheI– NheI fragment containing the ‘‘SV40-Hygr’’ resulting in pKAL074. pKAL074 was used to delete se-
cassette was inserted in the sense orientation into the quences in stem loop I (nt 8006–8038), stem loop III (nt
unique NheI site in the env gene (Fig. 1). This clone was 8149–8190), and stem loops I and III, simultaneously
named pKAL048; it contains a 613-bp deletion (nt 7578 – resulting in pKAL076, pKAL077, and pKAL078, respec-
8191) from the first BglII site in env to the start of the tively. Additional 9-bp insertional mutations were intro-
PPT. In the process, 427 bp of the env gene and most duced into pKAL074 between nt 8037 and 8038 at site
of the CTE (186 bp) were deleted except for 50 bp con- B, between nt 8073 and 8074 at site C, and between nt
sisting of 4 bp 5* to the PPT, 11 bp of the PPT, and 35 8089 and 8090 at site D in stem loops I and II, resulting
bp of U3 sequences in the 3* LTR which were kept to in pKAL079, pKAL080, and pKAL081, respectively. All mu-
avoid disrupting sequences important in the initiation of tations were verified by fmol sequencing as specified
the plus-strand DNA synthesis (Smith et al., 1984). above. Details of the design and construction of these
pKAL039 was created by re-introducing the CTE into vectors can be obtained from the authors upon request.
pKAL048, while maintaining the aforementioned deletion
in env (Fig. 1). A BamHI fragment containing 234 bp of Env-gp expression plasmids
the MPMV CTE from pTR225 was inserted in the correct
orientation at the BglII site in pKAL048, resulting in To construct an MPMV env expression plasmid,
pTR283 (Fig. 3), a 2196-bp region (nt 6224–8420) con-pKAL039. An identical clone containing the CTE in the
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taining env and CTE was PCR-amplified using S primer Viral stocks were harvested 72 hr posttransfection and
subjected to low-speed centrifugation to remove cellu-OTR119 (5* TTTCCCTTGTCGACAGATATGAA 3*; nt
6224–6246; this oligonucleotide creates a unique SalI lar debris. A portion of the viral stock was used to infect
HeLaT4 cells in the presence of 8 mg/ml DEAE – dextransite upstream of the env initiation codon by mutating
two nucleotides, shown in bold letters) and AS primer (Pharmacia, Piscataway, NJ). Forty-eight hours postin-
fection, selection for hygromycin resistance was initi-OTR120 (5* TTATATACACAGGCAGCAAG 3*; nt 8420 –
8401; a primer complementary to sequences in the 3* ated by replacing old media with media containing 200
mg/ml hygromycin B (Calbiochem, La Jolla, CA). AfterLTR). The resulting PCR product was digested with the
artificially created SalI site and the naturally occurring 9 – 11 days, hygromycin-resistant (Hygr) colonies were
either stained with 0.5% crystal violet in 50% methanolSphI and ligated into the SalI and SphI sites of pIC20R
(Marsh et al., 1984). To avoid sequencing the entire PCR- and counted or pooled and expanded to prepare geno-
mic DNA.amplified env region, a 1693-bp fragment internal to the
PCR product was exchanged with the wild-type region
Ultracentrifugation of viral particles and reverseusing the SpeI and SphI sites (nt 6680–8373), resulting
transcriptase (RT) assayin pTR275. The sequence of the remaining PCR-amplified
env region was verified by sequencing. Next, a SalI–XhoI
To determine whether viral particles containing RT ac-
fragment from pTR275 containing MPMV env and CTE
tivity were released from cells expressing MPMV vectors,
was cloned into the XhoI site of pZeoSV expression vec-
Cos cells were transfected as described above, and the
tor (Invitrogen, San Diego, CA), resulting in pTR283. To
medium was changed 24 hr posttransfection. After an
create an MPMV env expression vector without the CTE,
additional 48 hr, supernatants were harvested and clari-
pTR287, the MPMV env region was PCR-amplified using
fied of cellular debris by low-speed centrifugation in a
S primer OTR119 and AS primer OTR147 (5* GCTGTC-
table-top Sorvall centrifuge at 2500 rpm. Viral particles
CAGTCGACCTCACAGGGG 3*; nt 8033–8010; this oligo-
were pelleted by ultracentrifugation using a Sorvall
nucleotide creates a unique SalI site immediately down-
TH641 swinging bucket rotor at 80,000 g for 2 hr at 47
stream from the env stop codon by mutating two nucleo-
with a 20% sucrose cushion. Viral pellets, obtained from
tides, shown in bold letters, from the wild type). The
9 ml of supernatant, were resuspended in 50 ml of TNE
resulting PCR product was digested with SalI and cloned
buffer (50 mM Tris–Cl, pH 7.4, 100 mM NaCl, and 1 mM
into the XhoI site of pZeoSV in the sense orientation,
EDTA, pH 8.0) and stored at 0807.
creating pTR287 (Fig. 3).
The RT assay was performed by disrupting 10 ml of
Most of these clones were made through several
resuspended particles in 50 ml of RT cocktail (50 mM
stages of cloning, details of which can be obtained from
Tris–Cl, pH 7.8, 63 mM KCl, 4.2 mM MgCl2 , 0.08% Noni-the authors upon request.
det P-40, 0.85 mM EDTA, 4.2 mg/ml poly(A), and 0.13 mg/
Amphotropic murine leukemia virus (A-MLV) Env-gp
ml of oligo(dT). Eight microliters of 0.5 M DTT and 1 ml
expression plasmid pSV-A-MLV-env (Page et al., 1990),
of 10 mCi/ml of [32P]dTTP (NEN Dupont, Boston, MA) per
which expresses A-MLV Env-gp under the control of the
milliliter were added to this mix immediately before use,
MLV LTR, was obtained from the AIDS Research and
and the reaction mix was incubated at 377 for 1.5 hr. Ten
Reference Reagent Program of the National Institutes of
microliters of the reaction mix was spotted onto a DEAE
Health. pCMV-HIV-1-Env expresses the env gene of HIV-
filtermat (Wallac No. 1205-405), washed four times with
1-HXB-2 under the control of human cytomegalovirus
21 SSC for 5 min each and once with ethanol, dried, and
(CMV) promoter and was kindly provided by Dr. Harriet
counted in the Wallac 1409 liquid scintillation counter
Robinson, and pCMV-HIV-2-Env expresses the env gene
(Wallac, Gaithersburg, MD).
of HIV-2-Rod also under the control of human CMV pro-
moter and was kindly provided by Dr. Antonito Pangani- RNA fractionation and slot blot analysis
ban. The Rev-expression plasmid, pCMV-rev (Lewis et
al., 1990), expresses the HIV-1 Rev under the control Seventy-two hours posttransfection, cells were trypsin-
ized, washed in 11 phosphate-buffered saline (PBS), andof the simian CMV immediate early promoter and was
obtained from the AIDS Research and Reference Re- processed for RNA fractionation. RNA was isolated using
the Qiagen RNeasy Total RNA kit. Briefly, cytoplasmicagent Program of the National Institutes of Health.
RNA was isolated by lysing cells on ice in the lysing
buffer (50 mM Tris–Cl, pH 8, 140 mM NaCl, 1.5 mMTransfections and infections of cells
MgCl2 , and 0.5% Nonidet P-40). b-Mercaptoethanol (b-
ME) at 10 ml/ml and RNasin at 1000 U/ml were addedCos cells were maintained at 377 in Dulbecco’s modi-
fied Eagle’s medium supplemented with 10% fetal bo- to the buffer immediately before use. The lysates were
centrifuged at 47 for 2 min at 300 g and the supernatantvine serum from Hyclone (Logan, UT). In order to provide
Env-gp in trans, MPMV vectors were cotransfected indi- was transferred to an RNase-free tube and processed
for cytoplasmic RNA isolation according to the manufac-vidually with different Env-gp expression plasmids into
Cos cells by the DEAE – dextran method (Cullen, 1988). turer’s recommended protocol. The resulting pellet con-
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TABLE 1taining the nuclear RNA and cell debris was collected
and processed for nuclear RNA extraction. Briefly, the Generation of MPMV Particles by trans Complementation of
nuclear pellet was resuspended in the RLT lysis buffer pKAL036 with Homologous and Heterologous Env-gpsa
(Qiagen) containing b-ME at 10 ml/ml. The suspension
Env-gp-expressing Titer bwas applied to the Qiashredder column and centrifuged
plasmids Description of Env-gp (CFU/ml { SD)at 12,000 rpm for 1 min to shear genomic DNA. The
lysate contained the nuclear RNA, which was isolated pTR283 MPMV Env; CTE(/) 404 { 9
according to the manufacturer’s recommendations. Fol- pTR287 MPMV Env; CTE(0) 0
pSV-A-MLV-env Murine amphotropic Env 2712 { 17lowing RNA isolation, both cytoplasmic and nuclear
pCMV-HIV-1 Env HIV-1-HXB-2 Env 56 { 4RNAs were treated with RNase-free DNase to eliminate
pCMV-HIV-2 Env HIV-2-Rod Env 7 { 1any contaminating DNA, and dilutions (1:1, 1:2, 1:4) of
RNA were transferred to nitrocellulose using the slot-blot a No Hyg r colonies were observed for any of the Env-gp-expressing
apparatus. The filter was hybridized with a 1.52-kb pol- plasmids, pKAL036 by itself, or mock transfected.
bData are the means of two independent experiments with two dupli-specific DNA probe (nt 3148–4672) (Fig. 5A) using the
cate samples per experiment.Rapid-hyb buffer (Amersham Life Sciences, Arlington
Heights, IL). To control for RNA amounts, further dilutions
of RNA (1:5, 1:25, 1:125) were transferred onto a separate
ing the hygr gene gave rise to Hygr colonies. The numbernitrocellulose filter and probed with a 2-kb human b-
of Hygr colonies obtained was directly proportional to theactin cDNA control probe from Clonetech (Palo Alto, CA).
amount of infectious virus produced. The virus particlesThe probes were labeled using the Redivue stabilized
produced were infectious for only one round of replica-[32P]dCTP (Amersham Life Sciences) and the Rediprime
tion since they lacked the env gene for further propaga-DNA Labeling System (Amersham Life Sciences). The
tion. This assay was designed based on other trans com-filter was washed, air-dried, and exposed to Kodak XAR-
plementation assays that have been used successfully5 X-ray film with a Du Pont Cronex Lightning-Plus intensi-
to study replication of HIV-1 (Page et al., 1990; Delwartfying screen. To quantitate relative intensities of signal
et al., 1992; Geraghty and Panganiban, 1993) and SIVin each band, the radioactive counts per minute (cpm)
(Rizvi and Panganiban, 1992a,b).were measured using a Betascope 603 blot analyzer (Be-
tagen, Mountain View, CA). Successful propagation of MPMV vectors by
homologous and heterologous Env-gps
RNA secondary structure analysis
To test the functionality of the trans complementation
The putative secondary RNA structure of the MPMV assay, the ability to propagate env-defective MPMV vec-
CTE (nt 8006–8240) was determined on a DEC- tors was studied using homologous and heterologous
Alphaserver 2100 5/250 computer using the MFold pro- Env-gps. The Env-gp-expressing plasmids used included
gram of the University of Wisconsin Genetics Computer the homologous MPMV Env-gp with CTE (pTR283) and
Group (GCG) software package. MFold predicts both op- without CTE (pTR287) (Fig. 3). In addition, several heterol-
timal and suboptimal secondary RNA structures with ogous Env-gp-expressing plasmids were used: pCMV-
minimal free energy using published criteria (Zuker, 1989; HIV-1 ENV from HIV-1, pCMV-HIV-2 ENV from HIV-2, and
Jaeger et al., 1989). an amphotropic Env-gp from murine leukemia virus (pSV-
A-MLV-env). A rev-expression plasmid, pCMV-rev, was
RESULTS provided in trans for the expression of RRE-containing
HIV-1 and HIV-2 env-expression plasmids. Vectors prop-Experimental approach
agated following trans complementation by Env-gps
were tested for infectivity using HeLaT4 cells.To study the role of CTE in the replication of MPMV,
a genetic complementation assay was developed that Table 1 shows results of several independent experi-
ments following genetic complementation between theallowed the study of MPMV replication over a single
round. This entailed the construction of several replica- env-defective MPMV vector, pKAL036, and a variety of
homologous and heterologous Env-gps. pTR283, encod-tion-defective MPMV vectors that contained a deletion
and a simultaneous insertion of a hygr gene ‘‘cassette’’ ing MPMV Env-gp with CTE, could trans-complement
pKAL036, giving rise to 404 colony-forming units (CFU)/expressed from an SV40 promoter/enhancer in their env
genes. Propagation of such vectors depended upon trans ml, whereas env expression plasmid pTR287, lacking
CTE, could not, suggesting that MPMV Env-gp expres-complementation by the env gene. Genetic complemen-
tation between the env-defective vector and env-express- sion is dependent upon the presence of CTE in cis.
pKAL036 could also be propagated using heterolo-ing plasmid generated virus particles able to infect sus-
ceptible cells. Infected cells were selected in medium gous Env-gps. The amphotropic Env-gp was the best in
its ability to pseudotype MPMV, giving rise to high titerscontaining hygromycin B. Only cells with successful inte-
gration of vector DNA into the host genome and express- of pseudotyped virus (2712 CFU/ml; Table 1), while the
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TABLE 2
Role of MPMV CTE and HIV-1 and SIV RREs in the Propagation of MPMV Vectorsa
Titer (CFU/ml { SD)b
Presence or absence
Vectors of cis-acting elements Mutation(s) in MPMV genome Rev(/) Rev(0)
pKAL036 CTE(/) SV-Hygr insertion and a 705-bp 2448 { 24 2712 { 17
deletion in env
pKAL048 CTE(0) SV-Hygr insertion, a 424-bp ND 0
deletion in env, and 180-bp
deletion of CTE up to the
start of PPT
pKAL039 CTE(/) (S) Same as in pKAL048 with a ND 2064 { 20
reinsertion of CTE in the
sense orientation
pKAL044 CTE(/) (AS) Same as in pKAL048 with a ND 0
reinsertion of CTE in the
antisense orientation
pKAL051 CTE(0); HIV-1 RRE (S) Same as in pKAL048 with an 468 { 14 0
insertion of HIV-1 RRE in the
sense orientation
pKAL052 CTE(0); HIV-1 RRE (AS) Same as in pKAL048 with an 0 0
insertion of HIV-1 RRE in the
antisense orientation
pKAL053 CTE(0); SIV RRE (S) Same as in pKAL048 with an 384 { 9 0
insertion of SIV RRE in the
sense orientation
pKAL054 CTE(0); SIV RRE (AS) Same as in pKAL048 with an 0 0
insertion of SIV RRE in the
antisense orientation
Note. ND, not done; S, sense orientation; AS, anti-sense orientation.
a No Hyg r colonies were observed for any of the vectors when the trans-complementation assay was performed without pSV-A-MLV-env, pSV-A-
MLV-env by itself, or mock transfected.
b Data are the means of two independent experiments with two duplicate samples per experiment.
HIV-2 Env-gp was the least efficient in its ability to pseu- assay lay with its ability to carry out a single round of
replication, we wanted to test for the generation, if any,dotype pKAL036, giving rise to very low titers of pseu-
dotyped virus (7 CFU/ml). HIV-1 Env-gp was intermediate of replication-competent viruses using both the homolo-
gous and heterologous Env-gps. Thus, supernatants fromin its ability to pseudotype pKAL036 (56 CFU/ml). Interest-
ingly, the homologous Env-gp expression plasmid, Hygr colonies generated by viruses propagated using the
homologous MPMV Env-gp (pTR283) and the heterolo-pTR283, was sevenfold less efficient in its ability to res-
cue virus replication than the A-MLV Env-gp (404 CFU/ gous A-MLV Env-gp (Fig. 3) were harvested and used
to infect fresh HeLaT4 cells in the presence of DEAE–ml vs 2712 CFU/ml). Based on these results, we decided
to use the heterologous A-MLV Env-gp in the trans com- dextran; infected cells were selected for hygromycin B
resistance. In both cases, no Hygr colonies were ob-plementation experiments to study the role of CTE in
MPMV replication. tained, indicating that vector propagation was limited to a
single round and no replication-competent viral genomesThe Hygr colonies observed in the trans complementa-
tion assay were the result of successful infection events were generated by recombination using either the homol-
ogous or the heterologous Env-gp. Therefore, we con-by the fully complemented MPMV genome. However,
some colonies could also have arisen due to break- cluded that the level of recombination yielding replica-
tion-competent viruses was below the level of detectionthrough in drug selection or spurious transfection with
plasmid DNA carried over from Cos cell transfection. To in our system and we could use this assay to study the
role of CTE in the replication of MPMV in an unambigu-eliminate these possibilities, Hygr colonies were ex-
panded, DNA was isolated, and Southern blot hybridiza- ous and quantitative manner.
tion performed to detect the presence of plasmid DNA
versus MPMV viral DNA. Such analyses revealed that CTE is critical for the ability of MPMV to replicate
the Hygr colonies were a result of retrovirus-mediated
integration of viral DNA; no evidence of integration of To study the role of CTE in the replication of MPMV,
a set of molecular clones were generated that containedplasmid DNA was found (data not shown).
Since the strength of our genetic complementation a deletion and an insertion of the ‘‘SV40-Hygr’’ cassette
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in their env genes in the presence or absence of CTE.
Table 2 reveals the results of several trans complementa-
tion assays performed using the CTE(/) and CTE(0)
MPMV molecular clones. The CTE(/) vector, pKAL036,
containing the entire MPMV genome except for the dele-
tion and insertion mutations in the env gene, propagated
well, giving rise to 2712 CFU/ml of virus stock. When
CTE was deleted, as in the case of pKAL048, virus repli-
cation was completely abrogated and no Hygr colonies
were observed. However, when sequences encom-
passing the CTE were reinserted in the sense orientation,
generating pKAL039, virus replication was restored to
nearly wild-type levels (2064 CFU/ml). The somewhat
lower titers observed in case of pKAL039 may reflect the
effect of duplication of the PPT and U3 region of the 3*
LTR of the viral genome in which the CTE was reinserted.
Insertion of CTE in the antisense orientation, as in FIG. 4. Quantitation of RT-containing viral particles released from
pKAL044, could not rescue virus replication (Table 2). Cos cells transfected with MPMV vectors as measured by counts per
minute (see Materials and Methods for details). HIV-1 and SIV RRE-Thus, CTE was critical in the ability of MPMV to replicate
containing plasmids (pKAL051, pKAL052, pKAL053, and pKAL054) wereand produce infectious virions and functioned only in the
cotransfected with a HIV-1 Rev-expressing plasmid, pCMV-rev. Thesense orientation, as reported for HIV-1 (Bray et al., 1994)
amount of reverse transcriptase activity observed in pelleted particles
and SIV (Rizvi et al., 1996). is presented as a percentage of the wild-type CTE-containing vector,
pKAL036, with the background counts subtracted from the values
shown. Mock, mock-transfected cells.HIV-1 and SIV RREs can complement the function of
CTE in the life cycle of MPMV
interaction. Indeed, 10% lower titers of virus were pro-We next attempted to test if the HIV-1 and SIV Rev/
duced by pKAL036 in the presence of Rev (2448 CFU/ml)RRE regulatory system could complement the role of CTE
than in its absence (2712 CFU/ml), suggesting a possiblein the replication of MPMV. Therefore, HIV-1 and the SIV
competition of Rev with a Rev-like cellular factor thatRREs were inserted in the sense or antisense orientation
binds CTE or a cellular factor that interacts with the acti-in the MPMV CTE(0) vector, pKAL048 (Table 2). Insertion
vation domain of Rev. Overexpression of Rev, therefore,of HIV-1 RRE (pKAL051) or SIV RRE (pKAL053) in the
could inhibit processing of CTE-dependent mRNAs.sense orientation and provision of Rev in trans resulted
In addition to virus expression at the RNA level, wein the restoration of viral replication, albeit at a five- to
also determined whether the inappropriate regulation ofsixfold lower level than observed with CTE(/) vector,
viral messages lead to inappropriate release of progenypKAL036 (Table 2). In the presence of Rev, pKAL051 and
virions from transfected cells. Toward this end, thepKAL053 yielded 468 and 384 CFU/ml of virus, respec-
CTE(/), CTE(0), and HIV-1/SIV RRE(/) MPMV moleculartively, compared with 2712 CFU/ml obtained using
clones were transfected into Cos cells and supernatantspKAL036 (Table 2). The slightly lower titers observed in
harvested 72 hr posttransfection were tested for the re-the case of pKAL053, which contained the SIV RRE, com-
lease of virus particles by the RT assay (see Materialspared with pKAL051, which contained the HIV-1 RRE,
and Methods). Results obtained with the RT assaymay partly be explained by the use of HIV-1 Rev instead
agreed with those obtained with the single round of repli-of SIV Rev in the trans complementation assay. As ex-
cation assay (Fig. 4 and Table 2). MPMV clones defectivepected, rescue of virus replication did not occur in the
for CTE produced little or no RT compared to clonesabsence of Rev. MPMV replication could also not be
containing CTE, or clones containing HIV-1/SIV RRErescued when the HIV-1 RRE (pKAL052) or SIV RRE
when cotransfected with Rev in trans. These results con-(pKAL054) were inserted in the antisense orientation irre-
firm the importance of CTE in the MPMV life cycle andspective of the presence or absence of Rev (Table 2).
suggest that CTE may function in a manner similar toThese findings are consistent with earlier published re-
the Rev/RRE regulatory system of HIV-1/SIV.ports documenting that HIV-1 RRE functions only in the
sense orientation (Malim et al., 1989a).
Role of CTE in the transport of messages from the
Since there seemed to be functional similarity between
nucleus to the cytoplasm
CTE and RRE, we tried to detect any possible Rev/CTE
interactions by supplying HIV-1 Rev in trans to the CTE(/) Since the Rev/RRE regulatory system of HIV-1/SIV has
been shown to be important for the nucleocytoplasmicvector, pKAL036. If such an interaction existed, we should
have observed either higher or lower titers of virus in transport of unspliced and partially spliced messages,
we investigated the transport of MPMV mRNAs from thethe presence of Rev depending upon the nature of the
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FIG. 5. Slot blot analysis of fractionated RNAs isolated from Cos cells transfected with CTE(/) and CTE(0) MPMV vectors. (A) Schematic
representation of the wild-type vector, pKAL036, the two forms of mRNAs that it encodes, and the location of the 32P-labeled 1.52-kb pol-specific
DNA probe (shown as a black bar) used to detect the genomic and Gag/Pol message excluding the spliced Env mRNA. (B) Nuclear and cytoplasmic
RNA fractions were transferred onto a nitrocellulose filter using the slot-blot apparatus. Left panel shows an X-ray film of a filter probed with a
human b-actin cDNA control probe. Lanes 1, 2, and 3 refer to fivefold sequential dilutions of the nuclear and cytoplasmic RNAs. The right panel
shows an X-ray film of a filter probed with the pol-specific probe shown in above in part A. Lanes 1, 2, and 3 refer to twofold sequential dilutions
of the nuclear and cytoplasmic RNAs. (C) Betascope analysis of the filter hybridized with the pol-specific probe with the results presented as: the
proportion of counts per minute (cpms) observed in the cytoplasmic versus the nuclear fractions shown as a percentage of the total cpms, and the
relative ratio of the cpms observed in the cytoplasmic and nuclear fractions. Nuc., nuclear, and Cyt., cytoplasmic, RNA fractions; Mock, mock-
transfected cells.
nucleus to the cytoplasm to see if any disruption oc- revealed reduced amounts of MPMV-specific RNA in the
absence of CTE (Fig. 5B). Cells transfected with thecurred in the absence of CTE. Cos cells were transfected
with CTE(/) (pKAL036) and CTE(0) (pKAL048) MPMV CTE(/) vector, pKAL036, contained twofold more geno-
mic and Gag/Pol RNA in the nucleus than the cytoplasm.molecular clones, respectively. Nuclear and cytoplasmic
RNAs were fractionated 72 hr posttransfection and trans- In comparison, sixfold more MPMV RNA was found in
the nucleus of cells transfected with the CTE(0) vector,ferred onto a nitrocellulose filters using the slot-blot ap-
paratus. One filter was probed with a 1.52-kb pol-specific pKAL048, than the cytoplasm (Figs. 5B and 5C). This is
despite similar amounts of RNAs transferred onto nitro-DNA probe (nt 3148–4672) to detect the presence of
genomic and Gag/Pol messages (Fig. 5A), and a second cellulose as shown by the detection of the b-actin mes-
sage (Fig. 5B), suggesting aberrant nucleocytoplasmicfilter was probed with the human b-actin-specific cDNA
probe to control for RNA amounts. transport or instability of the genomic and the Gag/Pol
messages in the absence of CTE. When CTE was rein-Slot-blot analysis of the nuclear and cytoplasmic RNAs
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FIG. 6. Secondary RNA structure of MPMV CTE predicted by the University of Wisconsin GCG MFold analysis of optimal/suboptimal and minimal
free-energy folding. The region shown encompasses 234 nucleotides (nt 8006 to 8240) of the MPMV CTE. The gray area highlights the 9-bp region
of the CTE with 67% homology to the Rev-binding domain of HIV-1 RRE. Solid lines wrapping around stem loops I and III illustrate the extent of
deletions made in CTE for the mutational analysis. The boxed areas at sites A, B, C, and D show the points of insertional mutations into stem and
bulge areas of CTE in stem loops I, II, and III. Numbers in parentheses reflect the nucleotide numbers at the point of insertional mutations.
serted in the sense orientation in pKAL048, generating et al., 1990, 1992; Kjems et al., 1991). Hence, substitution
of the MPMV CTE function by the HIV-1 and SIV Rev/pKAL039, transport of the genomic and Gag/Pol mes-
RRE regulatory system may be evidence for a similarsages was restored as in the case of pKAL036 (data
protein/CTE interaction that stabilizes MPMV mRNAs ornot shown). These data suggest that CTE affects the
facilitates their export from the nucleus to the cytoplasm.nucleocytoplasmic transport and/or stability of the MPMV
To determine the relevance of the predicted RNA sec-genomic and Gag/Pol messages.
ondary structure to CTE function, a genetic approach
was employed to disrupt the predicted higher-orderMPMV CTE has the potential to form a stable
structure of CTE using two types of mutations. The firstsecondary RNA structure
category of mutations were designed to disrupt both the
The putative RNA secondary structure of the MPMV primary sequences and the predicted secondary struc-
CTE was predicted using the MFold program of the Uni- ture by deleting different regions of CTE. These deletions
versity of Wisconsin GCG sequence analysis software. removed sequences in stem loop 1 only (a 29-bp deletion
Figure 6 reveals the predicted RNA secondary structure removing the putative Rev-like binding domain), in stem
for MPMV CTE (nt 8006–8240) that displayed three stable loop III only (a 41-bp deletion), and in both stem loops I
stem loops each of which contained 2–4 bulge regions. and III (a total 70-bp deletion) (see Fig. 6 and Materials
Interestingly, a 9-bp tract at the 5* end of the CTE (5* and Methods). The second category of mutations were
CCCUGUGAG 3*; nt 8011–8019), which extends into designed to destabilize the predicted RNA secondary
stem loop I, was a 6/9 match for the Rev-binding se- structure by introducing 9-bp insertions of heterologous
sequences at sites B, C, and D (in stem loops I and II)quence (5* CACUAUGGG 3*) in the HIV-1 RRE (Holland
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TABLE 3
Effect of Deletion and Insertional Mutations in CTE on the Propagation of MPMV Vectorsa
Mutations in the predicted RNA secondary Titer b
Vectors structural elements of MPMV CTE (CFU/ml { SD)
pKAL036 CTE(/) 2695 { 11
pKAL048 CTE(0) 0
pKAL074 Insertion at site A 713 { 1
pKAL076 Deletion in stem loop I / site A insertion 3.0 { 4.2
pKAL077 Deletion in stem loop III / site A insertion 1.5 { 0.7
pKAL078 Deletion in stem loops I & III / site A insertion 4.0 { 4.2
pKAL079 Insertions at sites A / B 1.5 { 2.1
pKAL080 Insertions at sites A / C 8.0 { 4.2
pKAL081 Insertions at sites A / D 167 { 13
a No Hyg r colonies were observed for any of the vectors when the trans-complementation assay was performed without pSV-A-MLV-env, pSV-A-
MLV-env by itself, or mock transfected.
b Data are the means of two independent experiments with two duplicate samples per experiment.
of the predicted higher-order structure using SOE PCR served for pKAL074. The fact that CTE could not tolerate
most of the mutations introduced suggests the impor-(Fig. 6). To allow testing of these mutations in the single
round of replication assay, a plasmid was constructed tance of the predicted higher-order structure for CTE
function.that made it possible to clone the mutated CTEs into the
CTE(0) vector, pKAL048, without altering the genomic
position of CTE or duplicating any of its terminal se- DISCUSSION
quences. This was achieved by inserting a BglII site in
stem loop III at position A, and the mutated CTE con- In this study, we developed a genetic complementation
assay to analyze MPMV replication over a single round.taining the BglII insertion was cloned into pKAL048, re-
sulting in pKAL074. Testing of pKAL074 in the single The env-defective MPMV particles produced after the
first round of replication could not initiate another roundround of replication assay resulted in 75% reduction
in vector propagation (713 CFU/ml versus 2695 CFU/ml of infection without the presence of Env-gp. Replication-
defective vectors have been used previously to studyobserved for pKAL036; Table 3) suggesting the role of
higher-order structure for CTE function. To study the ef- recombination (Hu and Temin, 1990a), characterization
of frequency of mutation (Dougherty and Temin, 1988;fects of other mutations on the predicted structural ele-
ments of CTE, CTE fragments containing deletion and Pathak and Temin, 1990a,b), RNA packaging (Rizvi et
al., 1993; Mansky et al., 1995), and the nature of strandinsertional mutations were substituted for the homolo-
gous fragment in pKAL074. The resulting clones not only switching during reverse transcription (Hu and Temin,
1990b; Panganiban and Fiore, 1988). This trans comple-contained the deletion or insertional mutations, but also
the BglII insertion at site A. The mutated CTEs were mentation assay allowed us to measure the differing abil-
ities of the homologous Env-gp and a variety of heterolo-tested for effects on vector propagation in the single
round of replication assay. gous Env-gps to pseudotype MPMV. In addition, we
could directly study the effects of the lack of CTE on theTable 3 reveals the results of several trans comple-
mentation assays using MPMV vectors containing the replication of MPMV in a quantitative and reproducible
manner revealing that MPMV CTE was critical for themutant CTEs. Deletion of sequences in stem loop I con-
taining the Rev-like binding domain, or in stem loop III, replication of the virus. In the absence of CTE, sixfold
more MPMV RNA was found to be sequestered in theor in both stem loops I and III simultaneously resulted
in the abrogation of CTE function. These deletions could nucleus than in the cytoplasm. The function of CTE could
be substituted by HIV-1 and SIV Rev/RRE regulatory sys-have removed primary sequences important for CTE
function and/or destabilized putative RNA structural ele- tems. Computer analysis of sequences encompassing
CTE predicted a stable RNA secondary structure con-ments. Similarly, testing of mutant CTEs containing inser-
tions designed to disrupt the predicted CTE RNA second- taining three stem loop structures the first of which con-
tained a sequence motif similar to the Rev-binding do-ary structure revealed that CTE was unable to tolerate
most of the mutations introduced. The 9-bp insertions at main of HIV-1 RRE (Holland et al., 1990, 1992; Kjems
et al., 1991). Mutations designed to disrupt structuralsite B (at the base of stem loop I and II) and at site C
(bulge in stem loop II) were the most disruptive, render- elements of the predicted RNA secondary structure dras-
tically affected CTE function, suggesting the presence ofing CTE nonfunctional (Table 3). The insertion at the api-
cal bulge in stem loop II (site D) was the least disruptive, higher-order structure in CTE.
Several recent reports in the Rev/RRE system revealgiving rise to 167 CFU/ml compared to 713 CFU/ml ob-
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that the HIV-1 Rev activation domain acts as a nuclear cant deletion and a simultaneous insertion of the ‘‘SV40-
Hygr’’ cassette. These mutations could have affected envexport signal interacting with a nucleopore-associated
cofactor to facilitate the export of unspliced and partially splice site and/or any regulatory sequences that may
have been present in the Env ORF altering not only thespliced messages from the nucleus to the cytoplasm
(Bogerd et al., 1995; Fischer et al., 1995; Fritz et al., 1995; expression of Env-gp message, but also its potential reg-
ulation by the CTE. However, indirectly we were able toStutz et al., 1995). The functional and structural similari-
ties seen between MPMV CTE and HIV-1/SIV Rev/RRE show that MPMV CTE is important for the expression
of Env-gp. We were able to trans-complement the env-regulatory systems and the fact that MPMV does not
contain any accessory genes analogous to Rev to carry defective MPMV vector using only the MPMV Env-gp
expression plasmid containing the CTE, but not the sameout its function suggests that CTE may exploit cellular
host factors to carry out nucleocytoplasmic mRNA trans- plasmid without the CTE, revealing that CTE is important
for the expression of Env-gp from a heterologous pro-port and/or stabilize viral messages. Whatever the cellu-
lar factor(s) interacting with CTE are, they must be wide- moter (Table 1). We have made similar observations re-
garding the expression of MPMV gag/pol, which is CTE-spread like the nucleopore-associated proteins, since
we were able to get the same phenomenon in a variety dependent even when under the control of a heterolo-
gous promoter (unpublished observations).of cell lines including Cos, HOS (human osteosarcoma
cells), HeLa, and RD (rhabdomyosarcoma) (data not Analogous to the HIV-1/SIV Rev/RRE feedback loop,
it is possible that MPMV contains cis-acting repressorshown).
Several considerations dictated our selection of a het- sequences (CRS) that are counteracted by interaction of
CTE with cellular factors. The Rev/RRE regulatory systemerologous Env-gp to study the role of CTE in MPMV repli-
cation using the trans complementation assay. First, use has been shown to counteract the presence of several
CRS scattered throughout the HIV-1 genome (Cochraneof a heterologous Env-gp reduced chances of the env-
defective vector reacquiring the deleted env sequences et al., 1991; Maldarelli et al., 1991; Schwartz et al., 1992a).
The HIV-1 RRE itself has been shown to act as a CRSvia homologous recombination with the homologous
Env-gp. Second, we have shown that MPMV Env-gp ex- (Nasioulas et al., 1994; Brighty and Rosenberg, 1994).
The CRS retain viral messages containing the RRE se-pression is dependent on CTE. Therefore, it was neces-
sary to avoid any possible homologous recombination questered within the nucleus until Rev can overcome
the inhibition. Removal of the CRS results in Rev/RRE-between the CTE-containing sequences carried by the
env expression plasmid and sequences in the vector to independent expression of Gag/Pol proteins and replica-
tion of the virus (Schwartz et al., 1992a,b). Using a se-be packaged that could have resulted in the regeneration
of CTE in our CTE(0) molecular clones. Finally, in the creted alkaline phosphatase (SEAP) gene reporter assay,
our ongoing experiments suggests the presence of suchcase of HIV-1, pseudotyping with the murine amphotropic
Env-gp has been shown to produce higher titers of virus CRS in the MPMV genome (unpublished observations).
cis-acting repressor sequences have been shown to bethan trans complementation with the homologous Env-
gp (Page et al., 1990; Buchschacher and Panganiban, rich in adenylate (A) and uridylate (U) residues (Schwartz
et al., 1992a; Tan and Schwartz, 1995; Tan et al., 1995).1992; Delwart et al., 1992; Geraghty and Panganiban,
1993). We found this to be true in the case of MPMV AU-rich elements (AREs) may be a general feature of cellu-
lar and viral sequences (Caput et al., 1986; Shaw andalso; the murine amphotropic Env-gp turned out to be
the best (sevenfold better) in its ability to pseudotype Kamen, 1986; Schwartz et al., 1992a; Tan and Schwartz,
1995; Tan et al., 1995) and have been associated withMPMV than the homologous Env-gp. This may be due to
the ubiquitous and plentiful nature of the cellular receptor mRNA instability (Shaw and Kamen, 1986; Savant-Bhon-
sale and Cleveland, 1992; Chen and Shyu, 1994; Chen etwith which the amphotropic Env-gp interacts. It is not
known what the receptor for MPMV is, how good its al., 1994) and translatability (Tan and Schwartz, 1995; Tan
et al., 1995). Two AU-rich motifs, a pentanucleotide, AU-distribution on HeLaT4 cells is, and how permissive
HeLaT4 cells are compared with other cells to MPMV UUA (Caput et al., 1986), and an octanucleotide, UUU-
UUAUA (Kruys et al., 1989), have been found to be a com-infection.
Studies conducted in this paper provide direct evi- mon feature of the 3* untranslated regions (UTRs) of many
cellular mRNAs that are under posttranscriptional regula-dence that CTE is important for the nucleocytoplasmic
transport and/or stability of full-length genomic and un- tion, such as c-fos (Treisman, 1985; Wilson and Treisman,
1988; Shyu et al., 1989), c-myc (Rabbitts et al., 1985; Jonesspliced Gag/Pol messages (Fig. 5) . Threefold more full-
length RNA was found to be sequestered in the nucleus and Cole, 1987), and granulocyte-macrophage colony
stimulating factor (Shaw and Kamen, 1986). They are alsoof cells transfected with the CTE(0) vector, pKAL048,
compared with messages found in the nucleus of cells found in the late 3* untranslated region of viruses such
as human papillomavirus (HPV) type 1 (Tan and Schwartz,transfected with the CTE(/) vector, pKAL036 (Figs. 5B
and 5C). We purposely excluded the detection of the 1995), as well as in the coding sequences of viral genes
such as HIV-1-gag (Schwartz et al., 1992a) and HPV-16spliced Env-gp mRNA by selecting a pol-specific DNA
probe since MPMV env had been disrupted by a signifi- L1 (Tan et al., 1995).
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Computer analysis of the MPMV genome has revealed window of understanding into how simple retroviruses
replicate and interact with cellular machinery to carry outthat the entire viral genome is unusually AU rich (59%).
This is in contrast to most cellular mRNAs, which main- their life cycle and/or cause disease. The fact that a
similar element has been found in HBV important for thetain a 50% AU content (Schwartz et al., 1992a). We have
found multiple copies of the AU-rich motifs in the MPMV expression of its late gene products (Huang and Liang,
1993; Huang and Yen, 1994), while retroviral CTE andgag and pol genes. Specifically, the Gag ORF contains
1 copy of AUUUA, while Pol contains 10 copies of AUUUA Rev/RRE regulatory systems can overcome inhibition of
repressor sequences in HPV-1 and 16, suggests a com-and 1 copy of UUUUUAUA. At present, the role of AREs
in CTE dependence of MPMV mRNA transport, stability, mon evolutionary pathway used by both DNA and RNA
viruses to regulate expression of their late structuraland/or translation is not known. While we have demon-
strated that CTE plays a role in the nucleocytoplasmic genes via cis-acting elements that interact with trans-
acting viral or cellular factors.transport and/or stability of viral mRNAs, we cannot dis-
count the role of CTE in mRNA translational efficiency.
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